{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:24:41Z","timestamp":1774405481135,"version":"3.50.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Health and Family Planning Commission of Guangxi Zhuang Autonomous Region, Self-funded Projects","award":["Z-A20240492"],"award-info":[{"award-number":["Z-A20240492"]}]},{"name":"the Health and Family Planning Commission of Guangxi Zhuang Autonomous Region, Self-funded Projects","award":["Z-A20240515"],"award-info":[{"award-number":["Z-A20240515"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82104499"],"award-info":[{"award-number":["82104499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82160783"],"award-info":[{"award-number":["82160783"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation under","award":["2023GXNSFBA026146"],"award-info":[{"award-number":["2023GXNSFBA026146"]}]},{"name":"the Key Research Program of Guangxi Science and Technology Department","award":["AB21196010"],"award-info":[{"award-number":["AB21196010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24377-x","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:28:24Z","timestamp":1762518504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the molecular mechanism of apigenin in treating bronchiectasis based on network pharmacology and molecular docking"],"prefix":"10.1038","volume":"15","author":[{"given":"Haizhu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaochu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongxi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"24377_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","volume":"10","author":"S Aliberti","year":"2022","unstructured":"Aliberti, S. et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 10, 298\u2013306. https:\/\/doi.org\/10.1016\/S2213-2600(21)00277-0 (2022).","journal-title":"Lancet Respir Med."},{"key":"24377_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","volume":"11","author":"JD Chalmers","year":"2023","unstructured":"Chalmers, J. D. et al. Bronchiectasis in europe: data on disease characteristics from the European bronchiectasis registry (EMBARC). Lancet Respir Med. 11, 637\u2013649. https:\/\/doi.org\/10.1016\/S2213-2600(23)00093-0 (2023).","journal-title":"Lancet Respir Med."},{"key":"24377_CR3","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino, E. et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur. Respir J. 50, 1700629. https:\/\/doi.org\/10.1183\/13993003.00629-2017 (2017).","journal-title":"Eur. Respir J."},{"key":"24377_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2021.12.001","volume":"43","author":"JD Chalmers","year":"2022","unstructured":"Chalmers, J. D. Bronchiectasis from 2012 to 2022. Clin. Chest Med. 43, 1\u20136. https:\/\/doi.org\/10.1016\/j.ccm.2021.12.001 (2022).","journal-title":"Clin. Chest Med."},{"key":"24377_CR5","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1186\/s12889-024-19956-y","volume":"24","author":"L Wang","year":"2024","unstructured":"Wang, L., Wang, J., Zhao, G. & Li, J. Prevalence of bronchiectasis in adults: a meta-analysis. BMC Public. Health. 24, 2675. https:\/\/doi.org\/10.1186\/s12889-024-19956-y (2024).","journal-title":"BMC Public. Health"},{"key":"24377_CR6","doi-asserted-by":"publisher","first-page":"240096","DOI":"10.1183\/16000617.0096-2024","volume":"33","author":"H Choi","year":"2024","unstructured":"Choi, H. et al. Bronchiectasis in asia: a review of current status and challenges. Eur. Respir Rev. 33, 240096. https:\/\/doi.org\/10.1183\/16000617.0096-2024 (2024).","journal-title":"Eur. Respir Rev."},{"key":"24377_CR7","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.chest.2023.06.040","volume":"164","author":"JM Roberts","year":"2023","unstructured":"Roberts, J. M. et al. The economic burden of bronchiectasis: A systematic review. Chest 164, 1396\u20131421. https:\/\/doi.org\/10.1016\/j.chest.2023.06.040 (2023).","journal-title":"Chest"},{"key":"24377_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000490550","volume":"96","author":"PC Goeminne","year":"2018","unstructured":"Goeminne, P. C. & Vanfleteren, L. E. G. W. Bronchiectasis economics: spend money to save money. Respiration 96, 399\u2013402. https:\/\/doi.org\/10.1159\/000490550 (2018).","journal-title":"Respiration"},{"key":"24377_CR9","doi-asserted-by":"publisher","first-page":"1802392","DOI":"10.1183\/13993003.02392-2018","volume":"53","author":"WJ Guan","year":"2019","unstructured":"Guan, W. J., Han, X. R., de la Rosa-Carrillo, D. & Martinez-Garcia, M. A. The significant global economic burden of bronchiectasis: a pending matter. Eur. Respir J. 53, 1802392. https:\/\/doi.org\/10.1183\/13993003.02392-2018 (2019).","journal-title":"Eur. Respir J."},{"key":"24377_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/s-0041-1730891","volume":"42","author":"HR Keir","year":"2021","unstructured":"Keir, H. R. & Chalmers, J. D. Pathophysiology of bronchiectasis. Semin Respir Crit. Care Med. 42, 499\u2013512. https:\/\/doi.org\/10.1055\/s-0041-1730891 (2021).","journal-title":"Semin Respir Crit. Care Med."},{"key":"24377_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/thx.2003.008037","volume":"59","author":"AP Watt","year":"2004","unstructured":"Watt, A. P. et al. Neutrophil apoptosis, Proinflammatory mediators and cell counts in bronchiectasis. Thorax 59, 231\u2013236. https:\/\/doi.org\/10.1136\/thx.2003.008037 (2004).","journal-title":"Thorax"},{"key":"24377_CR12","doi-asserted-by":"publisher","first-page":"2400518","DOI":"10.1183\/13993003.00518-2024","volume":"63","author":"H Choi","year":"2024","unstructured":"Choi, H., McShane, P. J., Aliberti, S. & Chalmers, J. D. Bronchiectasis management in adults: state of the Art and future directions. Eur. Respir J. 63, 2400518. https:\/\/doi.org\/10.1183\/13993003.00518-2024 (2024).","journal-title":"Eur. Respir J."},{"key":"24377_CR13","first-page":"210","volume":"28","author":"A Triantafyllidi","year":"2015","unstructured":"Triantafyllidi, A., Xanthos, T., Papalois, A. & Triantafillidis, J. K. Herbal and plant therapy in patients with inflammatory bowel disease. Ann. Gastroenterol. 28, 210\u2013220 (2015).","journal-title":"Ann. Gastroenterol."},{"key":"24377_CR14","doi-asserted-by":"publisher","first-page":"5665778","DOI":"10.1155\/2022\/5665778","volume":"2022","author":"YL Lyu","year":"2022","unstructured":"Lyu, Y. L. et al. Biological activities underlying the therapeutic effect of quercetin on inflammatory bowel disease. Mediators Inflamm 2022, 5665778. https:\/\/doi.org\/10.1155\/2022\/5665778 (2022).","journal-title":"Mediators Inflamm"},{"key":"24377_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. & Supuran, C. T. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z (2021).","journal-title":"Nat. Rev. Drug Discov"},{"key":"24377_CR16","doi-asserted-by":"publisher","first-page":"201372","DOI":"10.1016\/j.humgen.2024.201372","volume":"43","author":"S Sabarathinam","year":"2025","unstructured":"Sabarathinam, S. Unveiling the therapeutic potential of Quercetin and its metabolite (Q3OG) for targeting inflammatory pathways in crohn\u2019s disease: A network Pharmacology and molecular dynamics approach. Hum. Gene. 43, 201372. https:\/\/doi.org\/10.1016\/j.humgen.2024.201372 (2025).","journal-title":"Hum. Gene"},{"key":"24377_CR17","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1021\/acs.jnatprod.4c00581","volume":"87","author":"D Domingo-Fern\u00e1ndez","year":"2024","unstructured":"Domingo-Fern\u00e1ndez, D. et al. Natural products have increased rates of clinical trial success throughout the drug development process. J. Nat. Prod. 87, 1844\u20131851. https:\/\/doi.org\/10.1021\/acs.jnatprod.4c00581 (2024).","journal-title":"J. Nat. Prod."},{"key":"24377_CR18","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/ptr.6647","volume":"34","author":"M Imran","year":"2020","unstructured":"Imran, M. et al. Apigenin as an anticancer agent. Phytother Res. 34, 1812\u20131828. https:\/\/doi.org\/10.1002\/ptr.6647 (2020).","journal-title":"Phytother Res."},{"key":"24377_CR19","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.3390\/ijms25095041","volume":"25","author":"K Charri\u00e8re","year":"2024","unstructured":"Charri\u00e8re, K. et al. Exploring the role of apigenin in neuroinflammation: insights and implications. Int. J. Mol. Sci. 25, 5041. https:\/\/doi.org\/10.3390\/ijms25095041 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"24377_CR20","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1021\/jf000892m","volume":"49","author":"KH Miean","year":"2001","unstructured":"Miean, K. H. & Mohamed, S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 49, 3106\u20133112. https:\/\/doi.org\/10.1021\/jf000892m (2001).","journal-title":"J. Agric. Food Chem."},{"key":"24377_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/ijms20061305","volume":"20","author":"B Salehi","year":"2019","unstructured":"Salehi, B. et al. The therapeutic potential of apigenin. Int. J. Mol. Sci. 20, 1305. https:\/\/doi.org\/10.3390\/ijms20061305 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"24377_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","volume":"27","author":"S Shukla","year":"2010","unstructured":"Shukla, S. & Gupta, S. Apigenin: a promising molecule for cancer prevention. Pharm. Res. 27, 962\u2013978. https:\/\/doi.org\/10.1007\/s11095-010-0089-7 (2010).","journal-title":"Pharm. Res."},{"key":"24377_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08923973.2019.1688345","volume":"42","author":"P Chen","year":"2020","unstructured":"Chen, P. et al. Apigenin exhibits anti-inflammatory effects in LPS-stimulated BV2 microglia through activating GSK3\u03b2\/Nrf2 signaling pathway. Immunopharmacol. Immunotoxicol. 42, 9\u201316. https:\/\/doi.org\/10.1080\/08923973.2019.1688345 (2020).","journal-title":"Immunopharmacol. Immunotoxicol"},{"key":"24377_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.31083\/j.fbl2810237","volume":"28","author":"IG Lee","year":"2023","unstructured":"Lee, I. G., Lee, J., Hong, S. H. & Seo, Y. J. Apigenin\u2019s therapeutic potential against viral infection. Front. Biosci. (Landmark Ed). 28, 237. https:\/\/doi.org\/10.31083\/j.fbl2810237 (2023).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"24377_CR25","doi-asserted-by":"publisher","first-page":"e22290","DOI":"10.1016\/j.heliyon.2023.e22290","volume":"9","author":"L Zhu","year":"2023","unstructured":"Zhu, L., Zhang, H., Zhang, X., Xia, L. & Zhang, J. Research progress on antisepsis effect of apigenin and its mechanism of action. Heliyon 9, e22290. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22290 (2023).","journal-title":"Heliyon"},{"key":"24377_CR26","doi-asserted-by":"publisher","first-page":"e13950","DOI":"10.1111\/jfbc.13950","volume":"46","author":"P Kashyap","year":"2022","unstructured":"Kashyap, P., Shikha, D., Thakur, M. & Aneja, A. Functionality of apigenin as a potent antioxidant with emphasis on bioavailability, metabolism, action mechanism and in vitro and in vivo studies: A review. J. Food Biochem. 46, e13950. https:\/\/doi.org\/10.1111\/jfbc.13950 (2022).","journal-title":"J. Food Biochem."},{"key":"24377_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-017-0179-x","volume":"7","author":"X Yan","year":"2017","unstructured":"Yan, X., Qi, M., Li, P., Zhan, Y. & Shao, H. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action. Cell. Biosci. 7, 50. https:\/\/doi.org\/10.1186\/s13578-017-0179-x (2017).","journal-title":"Cell. Biosci."},{"key":"24377_CR28","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1039\/c5fo01464f","volume":"7","author":"ZY Zhu","year":"2016","unstructured":"Zhu, Z. Y., Gao, T., Huang, Y., Xue, J. & Xie, M. L. Apigenin ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-l\u03b1 in rats. Food Funct. 7, 1992\u20131998. https:\/\/doi.org\/10.1039\/c5fo01464f (2016).","journal-title":"Food Funct."},{"key":"24377_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11418-021-01561-7","volume":"76","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Apigenin exerts chemopreventive effects on lung injury induced by SiO2 nanoparticles through the activation of Nrf2. J. Nat. Med. 76, 119\u2013131. https:\/\/doi.org\/10.1007\/s11418-021-01561-7 (2021).","journal-title":"J. Nat. Med."},{"key":"24377_CR30","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10787-022-00994-0","volume":"30","author":"A Rahimi","year":"2022","unstructured":"Rahimi, A., Alimohammadi, M., Faramarzi, F., Alizadeh-Navaei, R. & Rafiei, A. The effects of apigenin administration on the Inhibition of inflammatory responses and oxidative stress in the lung injury models: a systematic review and meta-analysis of preclinical evidence. Inflammopharmacology 30, 1259\u20131276. https:\/\/doi.org\/10.1007\/s10787-022-00994-0 (2022).","journal-title":"Inflammopharmacology"},{"key":"24377_CR31","doi-asserted-by":"publisher","first-page":"e37937","DOI":"10.1016\/j.heliyon.2024.e37937","volume":"10","author":"M Cai","year":"2024","unstructured":"Cai, M. et al. Insights into Diosgenin against inflammatory bowel disease as functional food based on network Pharmacology and molecular Docking. Heliyon 10, e37937. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37937 (2024).","journal-title":"Heliyon"},{"key":"24377_CR32","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/DDDT.S504671","volume":"19","author":"D Lu","year":"2025","unstructured":"Lu, D., Huang, L. & Weng, C. Unveiling the novel Anti - Tumor potential of Digitonin, a steroidal Saponin, in gastric cancer: A network Pharmacology and experimental validation study. Drug Des. Devel Ther. 19, 2653\u20132666. https:\/\/doi.org\/10.2147\/DDDT.S504671 (2025).","journal-title":"Drug Des. Devel Ther."},{"key":"24377_CR33","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/ph17111485","volume":"17","author":"Y Gu","year":"2024","unstructured":"Gu, Y. et al. Therapeutic effect of Shikimic acid on heat Stress-Induced myocardial damage: assessment via network Pharmacology, molecular Docking, molecular dynamics Simulation, and in vitro experiments. Pharmaceuticals (Basel). 17, 1485. https:\/\/doi.org\/10.3390\/ph17111485 (2024).","journal-title":"Pharmaceuticals (Basel)"},{"key":"24377_CR34","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41598-024-52413-9","volume":"14","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Network Pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer. Sci. Rep. 14, 1860. https:\/\/doi.org\/10.1038\/s41598-024-52413-9 (2024).","journal-title":"Sci. Rep."},{"key":"24377_CR35","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303 (2003).","journal-title":"Genome Res."},{"key":"24377_CR36","doi-asserted-by":"publisher","first-page":"240091","DOI":"10.1183\/16000617.0091-2024","volume":"33","author":"M Nigro","year":"2024","unstructured":"Nigro, M., Laska, I. F., Traversi, L., Simonetta, E. & Polverino, E. Epidemiology of bronchiectasis. Eur. Respir Rev. 33, 240091. https:\/\/doi.org\/10.1183\/16000617.0091-2024 (2024).","journal-title":"Eur. Respir Rev."},{"key":"24377_CR37","doi-asserted-by":"publisher","unstructured":"Mac Aog\u00e1in, M., Dicker, A. J., Mertsch, P. & Chotirmall, S. H. Infection and the Microbiome in bronchiectasis. Eur. Respir Rev. 33. https:\/\/doi.org\/10.1183\/16000617.0038-2024 (2024).","DOI":"10.1183\/16000617.0038-2024"},{"key":"24377_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/01635581.2019.1637006","volume":"72","author":"A Hazafa","year":"2020","unstructured":"Hazafa, A., Rehman, K. U., Jahan, N. & Jabeen, Z. The role of polyphenol (Flavonoids) compounds in the treatment of cancer cells. Nutr. Cancer. 72, 386\u2013397. https:\/\/doi.org\/10.1080\/01635581.2019.1637006 (2020).","journal-title":"Nutr. Cancer"},{"key":"24377_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nu12020457","volume":"12","author":"DM Kopustinskiene","year":"2020","unstructured":"Kopustinskiene, D. M., Jakstas, V., Savickas, A. & Bernatoniene, J. Flavonoids as anticancer agents. Nutrients 12, 457. https:\/\/doi.org\/10.3390\/nu12020457 (2020).","journal-title":"Nutrients"},{"key":"24377_CR40","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.3390\/molecules27134304","volume":"27","author":"R Abid","year":"2022","unstructured":"Abid, R. et al. Pharmacological properties of 4\u2019, 5, 7-Trihydroxyflavone (Apigenin) and its impact on cell signaling pathways. Molecules 27, 4304. https:\/\/doi.org\/10.3390\/molecules27134304 (2022).","journal-title":"Molecules"},{"key":"24377_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/ijms25010369","volume":"25","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. Luteolin alleviates oxidative stress in chronic obstructive pulmonary disease induced by cigarette smoke via modulation of the TRPV1 and CYP2A13\/NRF2 signaling pathways. Int. J. Mol. Sci. 25, 369. https:\/\/doi.org\/10.3390\/ijms25010369 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"24377_CR42","doi-asserted-by":"publisher","first-page":"175346662311708","DOI":"10.1177\/17534666231170800","volume":"17","author":"K Ding","year":"2023","unstructured":"Ding, K. et al. The therapeutic potential of Quercetin for cigarette smoking-induced chronic obstructive pulmonary disease: a narrative review. Ther. Adv. Respir Dis. 17, 17534666231170800. https:\/\/doi.org\/10.1177\/17534666231170800 (2023).","journal-title":"Ther. Adv. Respir Dis."},{"key":"24377_CR43","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00018-004-4189-6","volume":"61","author":"L R\u00f6nnstrand","year":"2004","unstructured":"R\u00f6nnstrand, L. Signal transduction via the stem cell factor receptor\/c-Kit. Cell. Mol. Life Sci. 61, 2535\u20132548. https:\/\/doi.org\/10.1007\/s00018-004-4189-6 (2004).","journal-title":"Cell. Mol. Life Sci."},{"key":"24377_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0898-6568(01)00271-6","volume":"14","author":"KM Nicholson","year":"2002","unstructured":"Nicholson, K. M. & Anderson, N. G. The protein kinase B\/Akt signalling pathway in human malignancy. Cell. Signal. 14, 381\u2013395. https:\/\/doi.org\/10.1016\/s0898-6568(01)00271-6 (2002).","journal-title":"Cell. Signal."},{"key":"24377_CR45","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","volume":"23","author":"I Hers","year":"2011","unstructured":"Hers, I., Vincent, E. E. & Tavar\u00e9, J. M. Akt signalling in health and disease. Cell. Signal. 23, 1515\u20131527. https:\/\/doi.org\/10.1016\/j.cellsig.2011.05.004 (2011).","journal-title":"Cell. Signal."},{"key":"24377_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.14670\/HH-26.651","volume":"26","author":"L Heron-Milhavet","year":"2011","unstructured":"Heron-Milhavet, L., Khouya, N., Fernandez, A. & Lamb, N. J. Akt1 and Akt2: differentiating the Aktion. Histol. Histopathol. 26, 651\u2013662. https:\/\/doi.org\/10.14670\/HH-26.651 (2011).","journal-title":"Histol. Histopathol"},{"key":"24377_CR47","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41598-018-19689-0","volume":"8","author":"S Duggal","year":"2018","unstructured":"Duggal, S. et al. Defining the Akt1 interactome and its role in regulating the cell cycle. Sci. Rep. 8, 1303. https:\/\/doi.org\/10.1038\/s41598-018-19689-0 (2018).","journal-title":"Sci. Rep."},{"key":"24377_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jnc.13415","volume":"139 Suppl 2","author":"B Vafadari","year":"2016","unstructured":"Vafadari, B., Salamian, A. & Kaczmarek, L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. J. Neurochem. 139 Suppl 2, 91\u2013114. https:\/\/doi.org\/10.1111\/jnc.13415 (2016).","journal-title":"J. Neurochem"},{"key":"24377_CR49","doi-asserted-by":"publisher","unstructured":"Huang, H. Matrix Metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances. Sens. (Basel). 18. https:\/\/doi.org\/10.3390\/s18103249 (2018).","DOI":"10.3390\/s18103249"},{"key":"24377_CR50","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.3390\/ijms231810571","volume":"23","author":"B Gajewska","year":"2022","unstructured":"Gajewska, B. & \u015aliwi\u0144ska-Mosso\u0144, M. Association of MMP-2 and MMP-9 polymorphisms with diabetes and pathogenesis of diabetic complications. Int. J. Mol. Sci. 23, 10571. https:\/\/doi.org\/10.3390\/ijms231810571 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"24377_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.imbio.2007.07.005","volume":"213","author":"E Kolaczkowska","year":"2008","unstructured":"Kolaczkowska, E., Arnold, B., Opdenakker, G. & Gelatinase B\/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils. Immunobiology 213, 109\u2013124. https:\/\/doi.org\/10.1016\/j.imbio.2007.07.005 (2008).","journal-title":"Immunobiology"},{"key":"24377_CR52","doi-asserted-by":"publisher","first-page":"240179","DOI":"10.1183\/16000617.0179-2024","volume":"34","author":"JD Chalmers","year":"2025","unstructured":"Chalmers, J. D. et al. Neutrophilic inflammation in bronchiectasis. Eur. Respir Rev. 34, 240179. https:\/\/doi.org\/10.1183\/16000617.0179-2024 (2025).","journal-title":"Eur. Respir Rev."},{"key":"24377_CR53","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1513\/AnnalsATS.201411-513OC","volume":"12","author":"SL Taylor","year":"2015","unstructured":"Taylor, S. L. et al. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Ann. Am. Thorac. Soc. 12, 701\u2013707. https:\/\/doi.org\/10.1513\/AnnalsATS.201411-513OC (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"24377_CR54","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/resp.12582","volume":"20","author":"WJ Guan","year":"2015","unstructured":"Guan, W. J. et al. Sputum matrix metalloproteinase-8 and \u2013\u20099 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications. Respirology 20, 1073\u20131081. https:\/\/doi.org\/10.1111\/resp.12582 (2015).","journal-title":"Respirology"},{"key":"24377_CR55","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1093\/nar\/gkz120","volume":"47","author":"EE Alemasova","year":"2019","unstructured":"Alemasova, E. E. & Lavrik, O. I. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins. Nucleic Acids Res. 47, 3811\u20133827. https:\/\/doi.org\/10.1093\/nar\/gkz120 (2019).","journal-title":"Nucleic Acids Res."},{"key":"24377_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-015-0448-8","volume":"12","author":"B Vuong","year":"2015","unstructured":"Vuong, B. et al. NF-\u03baB transcriptional activation by TNF\u03b1 requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1. J. Neuroinflammation. 12, 229. https:\/\/doi.org\/10.1186\/s12974-015-0448-8 (2015).","journal-title":"J. Neuroinflammation"},{"key":"24377_CR57","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.4049\/jimmunol.1000646","volume":"185","author":"M Zerfaoui","year":"2010","unstructured":"Zerfaoui, M. et al. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J. Immunol. 185, 1894\u20131902. https:\/\/doi.org\/10.4049\/jimmunol.1000646 (2010).","journal-title":"J. Immunol."},{"key":"24377_CR58","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","volume":"59","author":"PO Hassa","year":"2002","unstructured":"Hassa, P. O. & Hottiger, M. O. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell. Mol. Life Sci. 59, 1534\u20131553. https:\/\/doi.org\/10.1007\/s00018-002-8527-2 (2002).","journal-title":"Cell. Mol. Life Sci."},{"key":"24377_CR59","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/imm.12099","volume":"139","author":"MM Rosado","year":"2013","unstructured":"Rosado, M. M., Bennici, E., Novelli, F. & Pioli, C. Beyond DNA repair, the immunological role of PARP-1 and its siblings. Immunology 139, 428\u2013437. https:\/\/doi.org\/10.1111\/imm.12099 (2013).","journal-title":"Immunology"},{"key":"24377_CR60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1183\/09031936.00089008","volume":"33","author":"AS Naura","year":"2009","unstructured":"Naura, A. S. et al. Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur. Respir J. 33, 252\u2013262. https:\/\/doi.org\/10.1183\/09031936.00089008 (2009).","journal-title":"Eur. Respir J."},{"key":"24377_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel, B. & Schmid, J. A. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol. Cancer. 12, 86. https:\/\/doi.org\/10.1186\/1476-4598-12-86 (2013).","journal-title":"Mol. Cancer"},{"key":"24377_CR62","doi-asserted-by":"publisher","first-page":"L129","DOI":"10.1152\/ajplung.00261.2005","volume":"291","author":"D Okutani","year":"2006","unstructured":"Okutani, D., Lodyga, M., Han, B. & Liu, M. Src protein tyrosine kinase family and acute inflammatory responses. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L129\u2013L141. https:\/\/doi.org\/10.1152\/ajplung.00261.2005 (2006).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"24377_CR63","doi-asserted-by":"publisher","first-page":"8735","DOI":"10.4049\/jimmunol.181.12.8735","volume":"181","author":"Z Wang","year":"2008","unstructured":"Wang, Z., Rui, T., Yang, M., Valiyeva, F. & Kvietys, P. R. Alveolar macrophages from septic mice promote polymorphonuclear leukocyte transendothelial migration via an endothelial cell Src kinase\/NADPH oxidase pathway. J. Immunol. 181, 8735\u20138744. https:\/\/doi.org\/10.4049\/jimmunol.181.12.8735 (2008).","journal-title":"J. Immunol."},{"key":"24377_CR64","doi-asserted-by":"publisher","first-page":"L1164","DOI":"10.1152\/ajplung.00248.2005","volume":"290","author":"KS Farley","year":"2006","unstructured":"Farley, K. S. et al. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L1164\u2013L1172. https:\/\/doi.org\/10.1152\/ajplung.00248.2005 (2006).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"24377_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.prostaglandins.2015.01.001","volume":"116\u2013117","author":"J Hellmann","year":"2015","unstructured":"Hellmann, J. et al. Atf3 negatively regulates Ptgs2\/Cox2 expression during acute inflammation. Prostaglandins Other Lipid Mediat. 116\u2013117, 49\u201356. https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.01.001 (2015).","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"24377_CR66","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2019.04.015","volume":"288","author":"Z Ruan","year":"2019","unstructured":"Ruan, Z., Wang, S., Yu, W. & Deng, F. LncRNA MALAT1 aggravates inflammation response through regulating PTGS2 by targeting miR-26b in myocardial ischemia-reperfusion injury. Int. J. Cardiol. 288, 122. https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.015 (2019).","journal-title":"Int. J. Cardiol."},{"key":"24377_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","volume":"103","author":"AN Hata","year":"2004","unstructured":"Hata, A. N. & Breyer, R. M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103, 147\u2013166. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.06.003 (2004).","journal-title":"Pharmacol. Ther."},{"key":"24377_CR68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1194\/jlr.R800094-JLR200","volume":"50 Suppl","author":"EM Smyth","year":"2009","unstructured":"Smyth, E. M., Grosser, T., Wang, M., Yu, Y. & FitzGerald, G. A. Prostanoids in health and disease. J. Lipid Res. 50 Suppl, 423\u2013S428. https:\/\/doi.org\/10.1194\/jlr.R800094-JLR200 (2009).","journal-title":"J. Lipid Res."},{"key":"24377_CR69","doi-asserted-by":"publisher","first-page":"240055","DOI":"10.1183\/16000617.0055-2024","volume":"33","author":"L Perea","year":"2024","unstructured":"Perea, L., Faner, R., Chalmers, J. D. & Sibila, O. Pathophysiology and genomics of bronchiectasis. Eur. Respir Rev. 33, 240055. https:\/\/doi.org\/10.1183\/16000617.0055-2024 (2024).","journal-title":"Eur. Respir Rev."},{"key":"24377_CR70","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12967-025-06144-8","volume":"23","author":"B Zhang","year":"2025","unstructured":"Zhang, B., Leung, P. C., Cho, W. C. S., Wong, C. K. & Wang, D. Targeting PI3K signaling in lung cancer: advances, challenges and therapeutic opportunities. J. Transl Med. 23, 184. https:\/\/doi.org\/10.1186\/s12967-025-06144-8 (2025).","journal-title":"J. Transl Med."},{"key":"24377_CR71","doi-asserted-by":"publisher","first-page":"2301966","DOI":"10.1183\/13993003.01966-2023","volume":"64","author":"L Perea","year":"2024","unstructured":"Perea, L. et al. Airway IL-1\u03b2 is related to disease severity and mucociliary function in bronchiectasis. Eur. Respir J. 64, 2301966. https:\/\/doi.org\/10.1183\/13993003.01966-2023 (2024).","journal-title":"Eur. Respir J."},{"key":"24377_CR72","doi-asserted-by":"publisher","first-page":"2003157","DOI":"10.1183\/13993003.03157-2020","volume":"58","author":"YH Giam","year":"2021","unstructured":"Giam, Y. H., Shoemark, A. & Chalmers, J. D. Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism. Eur. Respir J. 58, 2003157. https:\/\/doi.org\/10.1183\/13993003.03157-2020 (2021).","journal-title":"Eur. Respir J."},{"key":"24377_CR73","doi-asserted-by":"publisher","first-page":"230234","DOI":"10.1183\/16000617.0234-2023","volume":"33","author":"E Johnson","year":"2024","unstructured":"Johnson, E., Long, M. B. & Chalmers, J. D. Biomarkers in bronchiectasis. Eur. Respir Rev. 33, 230234. https:\/\/doi.org\/10.1183\/16000617.0234-2023 (2024).","journal-title":"Eur. Respir Rev."},{"key":"24377_CR74","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molcel.2020.08.006","volume":"80","author":"K Klann","year":"2020","unstructured":"Klann, K. et al. Growth factor receptor signaling Inhibition prevents SARS-CoV-2 replication. Mol. Cell. 80, 164\u2013174e164. https:\/\/doi.org\/10.1016\/j.molcel.2020.08.006 (2020).","journal-title":"Mol. Cell."},{"key":"24377_CR75","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41392-020-0191-1","volume":"5","author":"M Catanzaro","year":"2020","unstructured":"Catanzaro, M. et al. Immune response in COVID-19: addressing a Pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal. Transduct. Target. Ther. 5, 84. https:\/\/doi.org\/10.1038\/s41392-020-0191-1 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"24377_CR76","doi-asserted-by":"publisher","first-page":"101480","DOI":"10.1016\/j.coviro.2025.101480","volume":"73","author":"T Shichijo","year":"2025","unstructured":"Shichijo, T. & Yasunaga, J. I. Human T-cell leukemia virus type I: modulation of viral gene expression and perturbation of host signaling pathways lead to persistent infection. Curr. Opin. Virol. 73, 101480. https:\/\/doi.org\/10.1016\/j.coviro.2025.101480 (2025).","journal-title":"Curr. Opin. Virol."},{"key":"24377_CR77","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3390\/cells13181512","volume":"13","author":"M Bakhanashvili","year":"2024","unstructured":"Bakhanashvili, M. The role of tumor suppressor p53 protein in HIV-Host cell interactions. Cells 13, 1512. https:\/\/doi.org\/10.3390\/cells13181512 (2024).","journal-title":"Cells"},{"key":"24377_CR78","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.4049\/jimmunol.173.9.5766","volume":"173","author":"C Desmet","year":"2004","unstructured":"Desmet, C. et al. Selective Blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J. Immunol. 173, 5766\u20135775. https:\/\/doi.org\/10.4049\/jimmunol.173.9.5766 (2004).","journal-title":"J. Immunol."},{"key":"24377_CR79","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/all.13760","volume":"74","author":"PJ Barnes","year":"2019","unstructured":"Barnes, P. J. Inflammatory endotypes in COPD. Allergy 74, 1249\u20131256. https:\/\/doi.org\/10.1111\/all.13760 (2019).","journal-title":"Allergy"},{"key":"24377_CR80","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10787-023-01416-5","volume":"32","author":"X Jia","year":"2024","unstructured":"Jia, X. et al. Quercetin attenuates Pseudomonas aeruginosa-induced acute lung inflammation by inhibiting PI3K\/AKT\/NF-\u03baB signaling pathway. Inflammopharmacology 32, 1059\u20131076. https:\/\/doi.org\/10.1007\/s10787-023-01416-5 (2024).","journal-title":"Inflammopharmacology"},{"key":"24377_CR81","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11626-022-00694-7","volume":"58","author":"X Guo","year":"2022","unstructured":"Guo, X., Pan, X., Wu, J., Li, Y. & Nie, N. Calycosin prevents IL-1\u03b2-induced articular chondrocyte damage in osteoarthritis through regulating the PI3K\/AKT\/FoxO1 pathway. Vitro Cell. Dev. Biol. Anim. 58, 491\u2013502. https:\/\/doi.org\/10.1007\/s11626-022-00694-7 (2022).","journal-title":"Vitro Cell. Dev. Biol. Anim."},{"key":"24377_CR82","doi-asserted-by":"publisher","first-page":"119320","DOI":"10.1016\/j.jep.2025.119320","volume":"343","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. Network pharmacology, molecular docking, and experimental verification reveal the mechanism of Yi-Shen-Hua-Shi granules treating acute kidney injury. J. Ethnopharmacol. 343, 119320. https:\/\/doi.org\/10.1016\/j.jep.2025.119320 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"24377_CR83","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/1389200220666190227224748","volume":"20","author":"X Sun","year":"2019","unstructured":"Sun, X., Chen, L. & He, Z. PI3K\/Akt-Nrf2 and Anti-Inflammation effect of macrolides in chronic obstructive pulmonary disease. Curr. Drug Metab. 20, 301\u2013304. https:\/\/doi.org\/10.2174\/1389200220666190227224748 (2019).","journal-title":"Curr. Drug Metab."},{"key":"24377_CR84","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.redox.2020.101544","volume":"33","author":"PJ Barnes","year":"2020","unstructured":"Barnes, P. J. Oxidative stress-based therapeutics in COPD. Redox Biol. 33, 101544. https:\/\/doi.org\/10.1016\/j.redox.2020.101544 (2020).","journal-title":"Redox Biol."},{"key":"24377_CR85","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","volume":"1863","author":"SMU Ahmed","year":"2017","unstructured":"Ahmed, S. M. U., Luo, L., Namani, A., Wang, X. J. & Tang, X. Nrf2 signaling pathway: pivotal roles in inflammation. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 585\u2013597. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.005 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"24377_CR86","doi-asserted-by":"publisher","first-page":"984","DOI":"10.17179\/excli2020-2579","volume":"19","author":"JK Kim","year":"2020","unstructured":"Kim, J. K. & Park, S. U. Recent insights into the biological functions of apigenin. EXCLI J. 19, 984\u2013991. https:\/\/doi.org\/10.17179\/excli2020-2579 (2020).","journal-title":"EXCLI J."},{"key":"24377_CR87","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2147\/COPD.S126102","volume":"12","author":"YF Chen","year":"2017","unstructured":"Chen, Y. F. et al. Bronchiectasis and increased risk of ischemic stroke: a nationwide population-based cohort study. Int. J. Chron. Obstruct Pulmon Dis. 12, 1375\u20131383. https:\/\/doi.org\/10.2147\/COPD.S126102 (2017).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"24377_CR88","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2015-208188","volume":"72","author":"V Navaratnam","year":"2016","unstructured":"Navaratnam, V. et al. Bronchiectasis and the risk of cardiovascular disease: a population-based study. Thorax 72, 161\u2013166. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-208188 (2016).","journal-title":"Thorax"},{"key":"24377_CR89","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12872-024-04129-x","volume":"24","author":"WC Kwok","year":"2024","unstructured":"Kwok, W. C. et al. Severe bronchiectasis is associated with increased carotid intima-media thickness. BMC Cardiovasc. Disord. 24, 457. https:\/\/doi.org\/10.1186\/s12872-024-04129-x (2024).","journal-title":"BMC Cardiovasc. Disord"},{"key":"24377_CR90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijpharm.2011.08.018","volume":"420","author":"L Al Shaal","year":"2011","unstructured":"Al Shaal, L., Shegokar, R. & M\u00fcller, R. H. Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. Int. J. Pharm. 420, 133\u2013140. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.08.018 (2011).","journal-title":"Int. J. Pharm."},{"key":"24377_CR91","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ejpb.2013.09.007","volume":"85","author":"CLN Vo","year":"2013","unstructured":"Vo, C. L. N., Park, C. & Lee, B. J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 85, 799\u2013813. https:\/\/doi.org\/10.1016\/j.ejpb.2013.09.007 (2013).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"24377_CR92","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ijpharm.2017.04.064","volume":"532","author":"R Karim","year":"2017","unstructured":"Karim, R. et al. Development and evaluation of injectable nanosized drug delivery systems for apigenin. Int. J. Pharm. 532, 757\u2013768. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.04.064 (2017).","journal-title":"Int. J. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24377-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:28:36Z","timestamp":1762518516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24377-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24377"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24377-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39161"}}